Orphazyme A/S ADR (ORPH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2005 | 12-2004 | 09-2004 | 06-2004 | 03-2004 | |
| Gross Profit | 7,160 | 5,170 | 6,200 | 4,670 | 4,770 |
| Operating Expenses | 2,560 | 3,110 | 2,930 | 2,960 | 4,220 |
| Operating Income | -2,560 | -3,110 | -2,930 | -2,960 | -4,220 |
| Pre-tax Income | -2,560 | -3,110 | -2,930 | -2,960 | -4,220 |
| Net Income Continuous | -2,560 | -3,110 | -2,930 | -2,960 | -4,220 |
| Net Income | $-2,560 | $-3,110 | $-2,930 | $-2,960 | $-4,220 |
| EBITDA(a) | $-2,460 | $-3,000 | $-2,810 | $-2,830 | $-4,110 |